<DOC>
	<DOC>NCT01037881</DOC>
	<brief_summary>This is a proof of concept and dose finding Phase II trial comparing 5 dose strengths with vehicle and an active comparator (Elidel cream 10 mg/g) in a 4 week, twice daily treatment regimen in mild to moderate atopic dermatitis patients.</brief_summary>
	<brief_title>LEO 29102 Cream in the Treatment of Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Clinical diagnosis of atopic dermatitis defined according to Hanifin and Rajka IGA assessment scored as mild (2) to moderate (3) atopic dermatitis Treatment lesions located on the trunk and limbs Treatment lesions involving 3% to 10% of the total body surface area Patients of either gender between 18 years and 65 years of age Systemic treatment with immunosuppressive drugs or corticosteroids within 6 weeks prior to randomisation Topical treatment with immunomodulators (pimecrolimus, tacrolimus) within 2 weeks prior to randomisation Topical treatment with corticosteroids from WHO groups II, III or IV within 1 week prior to randomisation Use of topical or systemic antibiotics within 2 weeks prior to randomisation PUVA or UVB therapy within 4 weeks prior to randomisation Clinical infection (viral, fungal or bacterial) on the treatment area Known or suspected severe renal insufficiency or severe hepatic disorders Patients with history of an immunocompromised disease (e.g., lymphoma, HIV, WiskottAldrich Syndrome) Patients with concomitant serious disease (e.g., cancer) which might affect the AD treatment in this trial Females who are pregnant or are breast feeding Females intending to temporarily or permanently stop their hormonal contraceptive regime during and up to one month post study termination visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>